Download PDF
Dtsch Med Wochenschr 2013; 138(12): 599
DOI: 10.1055/s-0032-1332904
Pro & Contra | Commentary
Kardiologie, Genetik
© Georg Thieme Verlag KG Stuttgart · New York

Die genetische Testung ist der Myokardbiopsie bei Kardiomyopathien überlegen – contra

Genetic testing is superior to biopsy of the myocardium in cardiomyopathy – no
H. P. Schultheiss
Further Information

Publication History

Publication Date:
12 March 2013 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

hypertrophe Kardiomyopathie (HCM) - dilatative Kardiomyopathie (DCM) - arrhythmogene rechtsven- trikuläre Kardiomyopathie (ARVC)

Keywords

hypertrophic cardiomyopathy - dilated cardiomyopathy - arrhythmogenic right ventricular cardiomyopathy
 

  • Literatur

  • 1 Ackermann MJ et al. HSR/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. Europace 2011; 13: 1077-1109
    CrossrefPubMedGoogle Scholar
  • 2 Andreasen C et al. New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants. Euro J Hum Genet 2013; doi: DOI: 10.1038/ejhg.2012.283.
    PubMedGoogle Scholar
  • 3 Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009; 30: 1995-2002
    CrossrefPubMedGoogle Scholar
  • 4 Kuehl U et al. Interferon-beta- improves survival in enterovirus-associated cardiomyopathy. J Am Coll Cardiol 2012; 60: 1295-1296
    CrossrefPubMedGoogle Scholar
  • 5 Schultheiss HP, Kuehl U, Cooper LT. The management of myocarditis. Eur Heart J 2011; 32: 2616-2665
    CrossrefPubMedGoogle Scholar
  • 6 van der Zwaag PA, van Tintelen JP. Counsel the genotype, treat the phenotype. Europ J Heart Failure 2011; 13: 1159-1160
    PubMedGoogle Scholar